Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
Marinus Pharmaceuticals | DEFA14A: Others
Marinus Pharmaceuticals | DEF 14A: Definitive information statements
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 8-K: Current report
No Data